Comparison Effectiveness of Distractions on Pain and Fear of Children

July 27, 2021 updated by: Sherzad Khudeida Suleman, University of Witten/Herdecke

Comparing The Effectiveness of Tracing Image and Coloring for Kids-Book With Two Passive Distractions on Pain and Fear in Children During Peripheral Intravenous Cannulation: A Randomized Controlled Trial

Distraction is a non-pharmacological technique that moves focus away from anxiety, discomfort or unpleasant stimulation to more stimulating or friendly stimulation. Distraction is one of the most effective, simplest and inexpensive non-pharmacological pain management methods (Hockenberry & Wilson, 2018). The benefits of using non-pharmacological methods include decreased pain, distress, and fear reported by the parent, child, and/or observer (Wente, 2013). There are two main types of distraction techniques: active and passive (Mutlu & Balcı, 2015; Wohlheiter & Dahlquist, 2013).

Objectives:

To evaluate the roles of the TICK-B, listening music, and watching cartoon, in relieving pain and fear of school-age children during PIVC.

To compare the effect of TICK-B with the effects of the listening music, and watching cartoon, on reducing pain and fear during PIVC in children.

To compare the effects of three distraction groups with the control group in relieving pain and fear during PIVC.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

Peripheral intravenous cannulation (PIVC) is an invasive technique. In this technique, a catheter is entrenched through the skin of the recipient into the lumen of a peripheral blood vein. It is the second most painful procedure performed in hospitals. Peripheral intravenous cannulation (PICV) is a common painful procedure for children, and nearly all ill children have experience with PIVC, and up to 80% of patients receive a peripheral venous cannula in a hospital. Therefore, the use of effective methods in pain and anxiety relief is very important during injection procedures in children.

In order to relieve pain and fear in children undergoing PICV. Psychological and physical approaches for coping with children's pain are favored, as well as pharmacological methods. Application of topical anesthetic creams is the most commonly used pharmacological solution to reduce pain associated with the medical procedure, or refrigerant preparations, however, only reduce the perception of pain in children during procedures. These approaches are not resolved anxiety, a core factor of noncooperation, which encumbers the efficiency of the needle procedure. For this cause, non-pharmacological approaches are generally recognized as alternative techniques, which may be used separately or in addition to pharmacological approaches, to provide sufficient pain and fear relief and to offer children a sense of control over the situation.

Study Type

Interventional

Enrollment (Anticipated)

150

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 12 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • School-aged 6-12 years old.
  • Children who require PIVC.

Exclusion Criteria:

  1. Respiratory chronic diseases,
  2. Physical impairment,
  3. Disability contributing to difficult communication,
  4. Children of unsatisfied parents,
  5. Children with neurodevelopment delay,
  6. Cognitive impairment, hearing impairment or a visual impairment,
  7. Taking an analgesic within 6 hours, or for those with a syncope history.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: TICK-B group as intervention group
TICK-B group: The children will receive the pictures they want. They will be asked to trace and color the pictures that need coloring. The nurse will color with children during the procedure. And after the procedure, the child will take his or her picture which he colored during the procedure.
These interventions will use as distraction techniques.
Other Names:
  • Control group or no intervention
  • Watching cartoons
  • Listening to music group
EXPERIMENTAL: Watching cartoons
Watching cartoons: In this group, children will watch cartoons as they like. Watching will continue until the procedure is complete.
These interventions will use as distraction techniques.
Other Names:
  • Control group or no intervention
  • Watching cartoons
  • Listening to music group
EXPERIMENTAL: Group listening to music
Listening to music: In this group, children will listen to cartoon music as they like. Listen will continue until the procedure is complete.
These interventions will use as distraction techniques.
Other Names:
  • Control group or no intervention
  • Watching cartoons
  • Listening to music group
NO_INTERVENTION: Standard care provided group as control group
Control group. The kids in this group will be allowed to keep their family near. The routine blood taking

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Faces Pain Scale-Revised to rate the severity of Pain (0-10) from no pain to worst pain
Time Frame: 5 minutes before procedure done.

To assess the intensity of pain related to Peripheral intravenous cannulation procedure in children:

Children will self-report their pain severity using the Faces Pain Scale-Revised, which has been validated and shown to be reliable.

5 minutes before procedure done.
Children's Fear Scale (CFS): Fear (0-4) no anxiety to extreme anxiety
Time Frame: 5 minutes before procedure done

To assess the fear level of the children related to Peripheral intravenous cannulation procedure:

Children will self-report their level of fear using the Children's Fear Scale (CFS), which has been validated and shown to be reliable.

5 minutes before procedure done

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Faces Pain Scale-Revised to rate the severity of Pain (0-10) from no pain to worst pain.
Time Frame: 0 minute during peripheral cannulation insertion procedure(time during insertion of cannula).

To assess the intensity of pain related to Peripheral intravenous cannulation procedure in children:

Children will self-report their pain severity using the Faces Pain Scale-Revised, which has been validated and shown to be reliable.

0 minute during peripheral cannulation insertion procedure(time during insertion of cannula).
Faces Pain Scale-Revised to rate the severity of Pain (0-10) from no pain to worst pain.
Time Frame: 1-2 minutes after procedure done.

To assess the intensity of pain related to peripheral intravenous cannulation procedure in children:

Children will self-report their pain severity using the Faces Pain Scale-Revised, which has been validated and shown to be reliable.

1-2 minutes after procedure done.
Children's Fear Scale (CFS): Fear (0-4) no anxiety to extreme anxiety
Time Frame: 0 minute during cannulation procedure.

To assess the fear level of the children related to peripheral intravenous cannulation procedure:

-Children will self-report their level of fear using the Children's Fear Scale (CFS), which has been validated and shown to be reliable.

0 minute during cannulation procedure.
Children's Fear Scale (CFS): Fear (0-4) no anxiety to extreme anxiety
Time Frame: 1-2 minute after cannulation procedure done.

To assess the fear level of the children related to peripheral intravenous cannulation procedure:

-Children will self-report their level of fear using the Children's Fear Scale (CFS), which has been validated and shown to be reliable.

1-2 minute after cannulation procedure done.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analog Scale (VAS), to measure the pain and Fear of children by the parents and observer.
Time Frame: Immediately after cannualtion (1-2 minutes after procedure to mask observer)
Visual Analog Scale (VAS) will be used to measure pain and fear of children by parent and observer.
Immediately after cannualtion (1-2 minutes after procedure to mask observer)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

July 28, 2021

Primary Completion (ANTICIPATED)

October 5, 2021

Study Completion (ANTICIPATED)

October 10, 2021

Study Registration Dates

First Submitted

July 4, 2021

First Submitted That Met QC Criteria

July 15, 2021

First Posted (ACTUAL)

July 26, 2021

Study Record Updates

Last Update Posted (ACTUAL)

August 3, 2021

Last Update Submitted That Met QC Criteria

July 27, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • Sherzad

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Peripheral Intravenous Cannulation

Clinical Trials on TICK-B group

3
Subscribe